Hla B*1502 Allele - Epidemiology

Relevant Publications

Carbamazepine-induced Stevens-Johnson Syndrome: A Case Report with Review of the Literature.

Issue Release: 2024

Unraveling the genetic link: an umbrella review on HLA-B*15:02 and antiepileptic drug-induced Stevens-Johnson syndrome/toxic epidermal necrolysis.

Issue Release: 2024

Cost-effectiveness analysis of HLA-B*15:02 screening before treatment of epilepsy in Indonesia.

Issue Release: 2024

Toxic Epidermal Necrolysis Observed in a Patient With the HLA-B*1502 Treated With Levofloxacin.

Issue Release: 2024

The impact on carbamazepine usage and cutaneous adverse reactions before and after the reimbursement of HLA-B*1502 genotyping in Taiwan, 2000-2017: A nationwide longitudinal study.

Issue Release: 2023

A Possible Type IV Hypersensitivity Reaction to Older Antiepileptic Drugs During and After Recovery from COVID-19 Infection.

Issue Release: 2021

Association between the HLA-B*1502 gene and mild maculopapular exanthema induced by antiepileptic drugs in Northwest China.

Issue Release: 2021

An alarm system of carbamazepine-induced toxic effects highly associated with HLA-B*1502 allele.

Issue Release: 2020

Investigating the association of Lamotrigine and Phenytoin-induced Stevens-Johnson syndrome/Toxic Epidermal Necrolysis with HLA-B*1502 in Iranian population.

Issue Release: 2020

HLA-A∗24:02 associated with lamotrigine-induced cutaneous adverse drug reactions: A systematic review and meta-analysis.

Issue Release: 2020

Cost-effectiveness of screening for HLA-B*1502 prior to initiation of carbamazepine in epilepsy patients of Asian ancestry in the United States.

Issue Release: 2019

Allergy to chlorpromazine and valproic acid following carbamazepine hypersensitivity in a patient with an HLA-B*4601 allele.

Issue Release: 2018

Association between HLA alleles and lamotrigine-induced cutaneous adverse drug reactions in Asian populations: A meta-analysis.

Issue Release: 2018

Association between HLA-A*3201 allele and oxcarbazepine-induced cutaneous adverse reactions in Eastern Han Chinese population.

Issue Release: 2018

HLA-B*1502 in Iranian Children with Anticonvulsant Drugs-Induced Skin Reactions.

Issue Release: 2017

[From facial pain to toxic epidermal necrolysis: a rare complication of carbamazepine usage].

Issue Release: 2017

CYP2C19*2 status in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis.

Issue Release: 2017

Personalized prescribing: a new medical model for clinical implementation of psychotropic drugs.

Issue Release: 2016

HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in Vietnamese.

Issue Release: 2015

Carbamazepine-Induced Incomplete Stevens-Johnson Syndrome: Report of a Case in Children without Mycoplasma pneumoniae Infection.

Issue Release: 2015

How is the RPR Test Used in Combination with Other Tests?

Why is HIPAA Important in Epidemiology?

What Types of Animals are Used?

Why Use SEIR Models?

What Are the Benefits of Mobile Health (mHealth) Interventions?

How is Ebola Virus Diagnosed?

How Are RCTs Conducted?

How is Safety Measured?

What Are Epidemiology Conferences?

How Are Random Networks Constructed?

Partnered Content Networks

Relevant Topics